{"metadata": {"source": "pubchem", "title": "Meperidine | C15H21NO2 | CID 4058 - PubChem", "description": "Meperidine | C15H21NO2 | CID 4058 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4058", "drug": "Meperidine", "cid": 4058, "char_count": 152237, "word_count": 20244, "doc_id": "doc_47", "num_chunks": 222, "chunk_id": "47::chunk_109", "document_index": 47, "latency_s": 1.0447374999930616, "prompt_toks": 39639, "completion_toks": 73, "relevance_score": 8.463939e-06}, "content": "Drug: Meperidine | cid: 4058\nSource: pubchem | Source description: Meperidine | C15H21NO2 | CID 4058 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meperidine is a potent opioid analgesic that has the potential for habit-forming and misuse, which increases the risk of overdose. Overdose of meperidine happens in:\n\nHaving an underlying or unknown condition that increases the sensitivity to meperidine\n\nAccidentally or intentionally using more than the prescribed dosage\n\nConcomitant use of meperidine with alcohol, other CNS depressants, or illicit drugs that alter the body's sensitivity to the medication\n\nSigns and Symptoms of Overdose\n\nPatients can have shallow or no breathing, signs of cyanosis like blue lips or fingernails, fatigue, convulsion, low blood pressure, bradycardia, constipation, stomach cramps, nausea and vomiting, cold and clammy skin, drowsiness, lightheadedness, and twitching muscles. In severe overdose, patients may experience circulatory relapse, cardiac arrest, apnea, and, in some cases, death.\n\nManagement of Overdose\n\n\n                    Context: \n                    This section details the toxicity management of meperidine, highlighting overdose signs such as respiratory depression, cyanosis, convulsions, and cardiovascular issues, and outlines related risk factors like underlying conditions and drug interactions. It emphasizes overdose symptoms and their clinical significance within the broader discussion of meperidine's safety, pharmacology, and adverse effects present in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Hydrocodone | C18H21NO3 | CID 5284569 - PubChem", "description": "Hydrocodone | C18H21NO3 | CID 5284569 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284569", "drug": "Hydrocodone", "cid": 5284569, "char_count": 134594, "word_count": 17516, "doc_id": "doc_39", "num_chunks": 185, "chunk_id": "39::chunk_81", "document_index": 39, "latency_s": 1.1421269999991637, "prompt_toks": 36021, "completion_toks": 48, "relevance_score": 7.12736e-06}, "content": "Drug: Hydrocodone | cid: 5284569\nSource: pubchem | Source description: Hydrocodone | C18H21NO3 | CID 5284569 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Signs and Symptoms of Overdose\n\nThe signs and symptoms of hydrocodone toxicity include apnea, breathing difficulties, bradycardia, miosis, clammy skin, cyanosis, hypotension, decreased level of consciousness, and loss of consciousness. Overdose-related pulmonary complications include noncardiogenic pulmonary edema and aspiration pneumonitis. Central respiratory depression leading to CO2 retention often results in respiratory acidosis.\n\nManagement of Overdose\n\n\n                    Context: \n                    This section details the signs, symptoms, and management strategies of hydrocodone overdose, providing critical clinical information on toxicity and emergency treatment, and is relevant for understanding drug safety, toxicology, and emergency response sections within the comprehensive drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "MDMA - PsychonautWiki", "description": "3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/MDMA", "drug": "MDMA", "cid": 1615, "char_count": 74065, "word_count": 10533, "doc_id": "doc_82", "num_chunks": 98, "chunk_id": "82::chunk_56", "document_index": 82, "latency_s": 0.9432575999962864, "prompt_toks": 18723, "completion_toks": 80, "relevance_score": 6.192364e-06}, "content": "Drug: MDMA | cid: 1615\nSource: psychonaut | Source description: 3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.\n\n                    Text: \n                    It was a main cause of the Death of Leah Betts who consumed an excstasy tablet followed by approximately 7 litres (1.8 US gal) of water in a 90 minute period, that resulted in water intoxication and hyponatremia, which in turn led to serious swelling of the brain, irreparably damaging it.\n\n\n                    Context: \n                    This excerpt highlights a critical real-world example of MDMA-related health risks, specifically water intoxication and hyponatremia, which can lead to fatal brain swelling. It relates to the document’s discussion on MDMA’s short-term physical health risks, overdose dangers, and harm reduction advice. The case of Leah Betts emphasizes the importance of controlled hydration and awareness of water intoxication symptoms during MDMA use.\n                "}
